- Trials with a EudraCT protocol (320)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
Query did not match any clinical trials.
| These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006). | |
| Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records. | |
| Study title: Sleep disordered breathing and daytime quality of life |
| Active substance: BUDESONIDE |
| Study summary document link (including results): Sleep disordered breathing and daytime quality of life in ch.pdf |
| View full study record |
| Document reference: 47748 |
| Study title: Russo−R−M, Gururaj−V−J, Allen−J−E. The effectiveness of diphenhydramine HCI in pediatric sleep disorders. Journal of clinical pharmacology, {J−Clin−Pharmacol}, May−Jun 1976, vol. 16, no. 5−6, p. 284−8. |
| Active substance: Dextromethorphan + Diphenhydramine + L-Menthol + Pseudoephedrine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25905 |
| Study title: Russo−R−M, Gururaj−V−J, Allen−J−E. The effectiveness of diphenhydramine HCI in pediatric sleep disorders. Journal of clinical pharmacology, {J−Clin−Pharmacol}, May−Jun 1976, vol. 16, no. 5−6, p. 284−8.Russo−R−M, Gururaj−V−J, Allen−J−E. The effectiveness of diphenhydramine HCI in pediatric sleep disorders. Journal of clinical pharmacology, {J−Clin−Pharmacol}, May−Jun 1976, vol. 16, no. 5−6, p. 284−8. |
| Active substance: DIPHENHYDRAMINE AND GUAIFENESIN AND L-MENTHOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26177 |
| Study title: Habre-Analgesic and respiratory effect of nalbuphine and pethidine for adenotonsillectomy in children with obstructive sleep disorder. |
| Active substance: NALBUPHINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32451 |
| Study title: Russo−R−M, Gururaj−V−J, Allen−J−E. The effectiveness of diphenhydramine HCI in pediatric sleep disorders. Journal of clinical pharmacology, {J−Clin−Pharmacol}, May−Jun 1976, vol. 16, no. 5−6, p. 284−8. |
| Active substance: CODEINE_AND_DIPHENHYDRAMINE_AND_L-MENTHOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24482 |
| Study title: Post-marketing surveillance study on the treatment of restlessness and nervous sleep disorder in children under 14 years of age (Euvegal® forte) |
| Active substance: HERB: dry extract from Valerian root (3 - 6 : 1), extraction agent: ethanol 62 % (w/w); dry extract from Balm leaves (4 - 6 : 1), extraction agent: ethanol 30 % (w/w)./ HERB: dry extract from Valerian root (4 - 5 : 1), dry extract from Balm leaves (4 - 6 : 1)./ HERB: Extract of Valerian root, corresp. to 640-800 mg drug; + Extract of Melissa leaf, corresp. 60 320-480 mg drug./ HERB: dry extract... |
| Study summary document link (including results): |
| View full study record |
| Document reference: 21221 |
| Study title: Sleep disorders in Children. Observational study with a high dosage valerian extract.; Hintelmann C. Schweiz. Z. Ganzheitsmed. 2002;14( ): 404-407 |
| Active substance: (HERB) Valeriana officinalis L. extract |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39724 |
| Study title: Reimão R, Lefévre AB.: Evaluation of flurazepam and placebo on sleep disorders in childhood. Arq Neuropsiquiatr. 1982 Mar;40(1):1-13. |
| Active substance: FLURAZEPAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28345 |
| Study title: VALUTAZIONE IN PEDIATRIA DELL'ATTIVITA' IPNOINDUCENTE DEL FLURAZEPAM GOCCE (VAL 779) Rapisarda V.; Germana B. Formazione Psichiatrica, December 1, 1980 , No. 4/- (181-190) Evaluation of flurazepam and placebo on sleep disorders in childhood. Reimão R, Lefévre AB. Arq Neuropsiquiatr. 1982 Mar;40(1):1-13. |
| Active substance: FLURAZEPAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28344 |
| Study title: "Le-Heuzey-M-F, Jacqz-Aigrain-E. M.F. Le Heuzey, Serv. Psychopathol. l'Enfant/l'Adol., Hopital Robert Debre, 48, boulevard Serurier, 75019 Paris, France e-mail: marie-france.leheuzey@rdb.ap-hop-paris.fr. Drugs and sleep disorders in children. Archives de Pediatrie {ARCH-PEDIATR}, 2002, Vol/Iss/Pg. 9/SUPPL. 2 (187s-189s), ISSN: 0929-693X." " "Le-Heuzey-M-F, Jacqz-Aigrain-E. M.F. Le Heuzey, Serv. Psychopathol. l'Enfant/l'Adol., Hopital Robert Debre, 48, boulevard Serurier, 75019 Paris, France e-mail: marie-france.leheuzey@rdb.ap-hop-paris.fr. Drugs and sleep disorders in children. Archives de Pediatrie {ARCH-PEDIATR}, 2002, Vol/Iss/Pg. 9/SUPPL. 2 (187s-189s), ISSN: 0929-693X." " |
| Active substance: PRAZEPAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34643 |
